American Century Companies Portfolio holdings
American Century Companies, Inc., founded in 1958 by James E. Stowers Jr. as Twentieth Century Mutual Funds and headquartered in Kansas City, Missouri, is a privately held investment management firm renowned for its focus on delivering investment results to clients while supporting medical research. Starting with just $100,000 from 24 shareholders, it rebranded to American Century Investments in 1997 and now manages hundreds of billions in assets across mutual funds, ETFs, and institutional portfolios, emphasizing no-load funds and a client-centric approach. The firm’s unique ownership structure sees over 40% of its profits funneled to the Stowers Institute for Medical Research, which it majority-owns, funding groundbreaking biomedical research, while Nomura Holdings holds a significant minority stake. With a global presence in cities like New York, London, and Hong Kong, and a workforce of around 1,400, American Century blends financial expertise with a mission to improve lives through both wealth creation and scientific advancement.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$706M |
| 2 |
Kenvue
KVUE
|
+$193M |
| 3 |
Alnylam Pharmaceuticals
ALNY
|
+$160M |
| 4 |
Entegris
ENTG
|
+$160M |
| 5 |
Merck
MRK
|
+$139M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Nike
NKE
|
+$301M |
| 2 |
Visa
V
|
+$269M |
| 3 |
Alphabet (Google) Class A
GOOGL
|
+$217M |
| 4 |
Allstate
ALL
|
+$172M |
| 5 |
Air Products & Chemicals
APD
|
+$163M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 25.13% |
| 2 | Financials | 13.26% |
| 3 | Healthcare | 12.32% |
| 4 | Consumer Discretionary | 12.01% |
| 5 | Industrials | 10.44% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2501
Colony Bankcorp
CBAN
$471M
| $396K | ﹤0.01% |
34,395
+4,302
| +14% | +$50.7K |
|
|
INZY
2502
DELISTED
Inozyme Pharma
INZY
| $394K | ﹤0.01% |
51,427
+22,732
| +79% | +$125K |
|
2503
GoPro
GPRO
$117M
| $393K | ﹤0.01% |
176,380
+39,734
| +29% | +$106K |
|
2504
BrightView Holdings
BV
$1.08B
| $393K | ﹤0.01% |
+33,035
| New | +$301K |
|
|
EPIX
2505
DELISTED
ESSA Pharma
EPIX
| $392K | ﹤0.01% |
46,176
+26,132
| +130% | +$228K |
|
|
GTY
2506
Getty Realty Corp
GTY
$2.05B
| $392K | ﹤0.01% |
14,322
+1,071
| +8% | +$29.4K |
|
2507
OmniAb
OABI
$499M
| $391K | ﹤0.01% |
72,073
+1,153
| +2% | +$6.64K |
|
|
KALV
2508
DELISTED
KalVista Pharmaceuticals
KALV
| $388K | ﹤0.01% |
32,723
+3,660
| +13% | +$48.8K |
|
|
VZIO
2509
DELISTED
VIZIO Holding Corp.
VZIO
| $387K | ﹤0.01% |
35,407
-3,354,574
| -99% | -$30.8M |
|
|
SHYF
2510
DELISTED
The Shyft Group
SHYF
| $386K | ﹤0.01% |
31,109
+7,218
| +30% | +$80.5K |
|
|
NTST
2511
NETSTREIT Corp
NTST
$2.09B
| $386K | ﹤0.01% |
20,995
+3,222
| +18% | +$57.1K |
|
|
FARO
2512
DELISTED
Faro Technologies
FARO
| $385K | ﹤0.01% |
17,910
+2,393
| +15% | +$51.9K |
|
|
LUCK
2513
Lucky Strike Entertainment
LUCK
$930M
| $385K | ﹤0.01% |
28,101
-265
| -0.9% | -$3.42K |
|
2514
Allient
ALNT
$1.86B
| $383K | ﹤0.01% |
+10,740
| New | +$321K |
|
2515
National CineMedia
NCMI
$252M
| $383K | ﹤0.01% |
74,378
+29,319
| +65% | +$125K |
|
2516
UNIFI
UFI
$120M
| $379K | ﹤0.01% |
63,282
+388
| +0.6% | +$2.35K |
|
2517
Atlanta Braves Holdings Series A
BATRA
$3.64B
| $379K | ﹤0.01% |
9,046
+3,460
| +62% | +$146K |
|
2518
Axogen
AXGN
$2.58B
| $378K | ﹤0.01% |
46,815
+29,913
| +177% | +$268K |
|
2519
iRadimed
IRMD
$1.11B
| $376K | ﹤0.01% |
8,555
+2,849
| +50% | +$126K |
|
|
ELME
2520
Elme Communities
ELME
$144M
| $376K | ﹤0.01% |
26,985
+3,488
| +15% | +$48.6K |
|
|
CCRD
2521
DELISTED
CoreCard
CCRD
| $374K | ﹤0.01% |
33,859
+2,229
| +7% | +$26.5K |
|
|
TDAY
2522
USA Today Co
TDAY
$1B
| $373K | ﹤0.01% |
153,016
+49,479
| +48% | +$111K |
|
2523
Brown-Forman Class A
BF.A
$13.1B
| $371K | ﹤0.01% |
7,010
-171
| -2% | -$9.77K |
|
2524
Silgan Holdings
SLGN
$4.46B
| $369K | ﹤0.01% |
7,590
+27
| +0.4% | +$1.2K |
|
|
TSVT
2525
DELISTED
2seventy bio
TSVT
| $367K | ﹤0.01% |
68,590
+23,246
| +51% | +$109K |
|
Similar funds
American Century Companies's Q1 2024 Portfolio in Review
As of Q1 2024, American Century Companies held 2,999 positions worth $159B, up 9.4% from $145B the previous quarter. Its ten largest holdings account for 24% of the portfolio.
American Century Companies's Q1 2024 filing shows 122 new, 1,903 increased, 717 reduced and 75 closed positions. Its largest new stake was Bombardier Recreational Products: 736,453 shares worth $49.4M. The largest sale was Nike, an estimated $301M.
By sector, the portfolio is most concentrated in Technology at 25% of assets, up from 24% a quarter earlier, followed by Financials and Healthcare.
- American Century Companies's largest Q1 2024 buy was Bombardier Recreational Products: 736,453 shares worth $49.4M.
- American Century Companies added most to Meta Platforms (Facebook) in Q1 2024, an estimated $706M increase.
- American Century Companies's biggest Q1 2024 reduction was Nike, cutting an estimated $301M.
- American Century Companies fully exited Mobileye in Q1 2024, selling an estimated $74.8M.
- American Century Companies's ten largest holdings make up 24% of its $159B portfolio in Q1 2024.
- American Century Companies opened 122 new positions and closed 75 in Q1 2024.
- American Century Companies's portfolio value rose 9.4% quarter-over-quarter to $159B.
Based on American Century Companies's 13F filing for Q1 2024, filed 14 May 2024.